Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on: January 07,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on:January 07,2024

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on: February 03,2024

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Updated on:February 03,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on: January 21,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on:January 21,2024

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on: February 20,2024

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on:February 20,2024

Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

by University of ZurichThe image-based consensus molecular subtypes (imCMS) model can be used to predict the molecular classification of each individual image region in patient tumor samples. Thi

Updated on: June 08,2024

Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

by University of ZurichThe image-based consensus molecular subtypes (imCMS) model can be used to predict the molecular classification of each individual image region in patient tumor samples. Thi

Updated on:June 08,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on: May 06,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on:May 06,2024

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Updated on: August 03,2024

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Updated on:August 03,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on: July 17,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on:July 17,2024

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on: January 07,2024

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on:January 07,2024

AI tool predicts cancer gene activity from biopsy images

by Sarah C.P. Williams,Stanford University Medical CenterA new AI program, SEQUOIA, can analyze a microscopy image from a tumor biopsy (left, purple) and rapidly determine what genes are likely

Updated on: November 30,2024

AI tool predicts cancer gene activity from biopsy images

by Sarah C.P. Williams,Stanford University Medical CenterA new AI program, SEQUOIA, can analyze a microscopy image from a tumor biopsy (left, purple) and rapidly determine what genes are likely

Updated on:November 30,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024